Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions

计划入组 150 人 · 首次发布于 2024 年 2 月 16 日

A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological Conditions

计划入组 10,000 人 · 首次发布于 2021 年 10 月 19 日

Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.

计划入组 9 人 · 首次发布于 2026 年 2 月 24 日

Mical-2

extracellular vesicle therapy (orthopedic conditions)

bispecific antibody (dermatological disorders)

SAMONCHO DERMATOLOGICAL CLINIC

Japan

Sonoma Pharmaceuticals

United States

Journey Medical

United States

New Topical Treatments Expand Options for Dermatological Conditions: Expert Highlights Ruxolitinib and Roflumilast Advances

Rubedo Life Sciences Reports Positive Phase 1 Results for First-in-Class GPX4 Modulator RLS-1496 in Dermatological Conditions

Phase 3b Study Shows Promise for Moderate Psoriasis in Sensitive Areas